Literature DB >> 19554360

The HMG-CoA reductase gene and lipid and lipoprotein levels: the multi-ethnic study of atherosclerosis.

Yi-Chun Chen1, Yii-Der I Chen, Xiaohui Li, Wendy Post, David Herrington, Joseph F Polak, Jerome I Rotter, Kent D Taylor.   

Abstract

HMG-CoA reductase (HMGCR) is an enzyme involved in cholesterol synthesis. To investigate the contribution of the HMGCR gene to lipids and lipoprotein subfractions in different ethnicities, we performed an association study in the Multi-Ethnic Study of Atherosclerosis (MESA). In total, 2,444 MESA subjects [597 African-Americans (AA), 627 Chinese-Americans (CHA), 612 European-Americans (EA), and 608 Hispanic-Americans (HA)] without statin use were included. Participants had measurements of blood pressure, anthropometry, and fasting blood samples. Subjects were genotyped for 10 single nucleotide polymorphisms (SNPs). After excluding SNPs with minor allele frequency <5%, a single block was constructed. The most frequent haplotype was H1 (41-56%) in all ethnic groups except AA (H2a, 44.9%). Lower triglyceride level was associated with the H2a haplotype in AA and H2 in HA. In HA, H4 carriers had higher levels of triglyceride and small low-density lipoprotein (s-LDL), and lower high-density lipoprotein cholesterol (HDL-c), while carriers with H7 or H8 had associations with these traits in the opposite direction. No significant association was discovered in both CHA and EA. The total variation for triglyceride that could be explained by H2 alone was 2.6% in HA and 1.4% in AA. In conclusion, HMGCR gene variation is associated with multiple lipid/lipoprotein traits, especially with triglyceride, s-LDL, and HDL-c. The impact of the genetic variance is modest and differs greatly among ethnicities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19554360      PMCID: PMC2760058          DOI: 10.1007/s11745-009-3314-6

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  35 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

3.  A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans.

Authors:  R Duggirala; J Blangero; L Almasy; T D Dyer; K L Williams; R J Leach; P O'Connell; M P Stern
Journal:  Am J Hum Genet       Date:  2000-03-21       Impact factor: 11.025

4.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

Authors:  S S Anand; S Yusuf; V Vuksan; S Devanesen; K K Teo; P A Montague; L Kelemen; C Yi; E Lonn; H Gerstein; R A Hegele; M McQueen
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

5.  Genetic control of coordinated changes in HDL and LDL size phenotypes.

Authors:  D L Rainwater; L J Martin; A G Comuzzie
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

6.  Unique lipoprotein phenotype and genotype associated with exceptional longevity.

Authors:  Nir Barzilai; Gil Atzmon; Clyde Schechter; Ernst J Schaefer; Adrienne L Cupples; Richard Lipton; Suzanne Cheng; Alan R Shuldiner
Journal:  JAMA       Date:  2003-10-15       Impact factor: 56.272

7.  Heritability of LDL peak particle diameter in the Quebec Family Study.

Authors:  Yohan Bossé; Marie-Claude Vohl; Jean-Pierre Després; Benoît Lamarche; Treva Rice; D C Rao; Claude Bouchard; Louis Pérusse
Journal:  Genet Epidemiol       Date:  2003-12       Impact factor: 2.135

8.  Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment.

Authors:  Ronald M Krauss; Lara M Mangravite; Joshua D Smith; Marisa W Medina; Dai Wang; Xiuqing Guo; Mark J Rieder; Joel A Simon; Steven B Hulley; David Waters; Mohammed Saad; Paul T Williams; Kent D Taylor; Huiying Yang; Deborah A Nickerson; Jerome I Rotter
Journal:  Circulation       Date:  2008-03-10       Impact factor: 29.690

9.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

10.  Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin.

Authors:  Marisa Wong Medina; Feng Gao; Weiming Ruan; Jerome I Rotter; Ronald M Krauss
Journal:  Circulation       Date:  2008-06-16       Impact factor: 29.690

View more
  5 in total

1.  A method to account for covariate-specific treatment effects when estimating biomarker associations in the presence of endogenous medication use.

Authors:  Andrew J Spieker; Joseph Ac Delaney; Robyn L McClelland
Journal:  Stat Methods Med Res       Date:  2016-12-22       Impact factor: 3.021

Review 2.  Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions.

Authors:  QiPing Feng; Russell A Wilke; Tesfaye M Baye
Journal:  Pharmacogenomics       Date:  2012-04       Impact factor: 2.533

3.  PharmGKB: very important pharmacogene--HMGCR.

Authors:  Marisa Wong Medina; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-02       Impact factor: 2.089

4.  Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life.

Authors:  Roya Kelishadi
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

5.  Extract of Wax Gourd Peel Prevents High-Fat Diet-Induced Hyperlipidemia in C57BL/6 Mice via the Inhibition of the PPARγ Pathway.

Authors:  Ming Gu; Shengjie Fan; Gaigai Liu; Lu Guo; Xiaobo Ding; Yan Lu; Yu Zhang; Guang Ji; Cheng Huang
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-25       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.